Detecting Anti-Drug Antibodies Using Immunogenicity Assays

Pall ForteBio immunogenicity assays enable the detection of anti-drug antibodies as a part of an immune response to a protein or antibody therapeutic. This application note describes protocols, biosensors and basic reagents required to run two different assay configurations: an enzyme-linked bridging assay and a direct binding assay. The assays are intended for use with human, primate and other animal serum and plasma samples.